KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $672.0 million.

  • Organon's Cash & Current Investments fell 1192.66% to $672.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $672.0 million, marking a year-over-year decrease of 1192.66%. This contributed to the annual value of $704.0 million for FY2024, which is 28.49% up from last year.
  • Per Organon's latest filing, its Cash & Current Investments stood at $672.0 million for Q3 2025, which was down 1192.66% from $599.0 million recorded in Q2 2025.
  • Organon's Cash & Current Investments' 5-year high stood at $1.0 billion during Q3 2021, with a 5-year trough of $141.0 million in Q1 2021.
  • Over the past 5 years, Organon's median Cash & Current Investments value was $672.0 million (recorded in 2025), while the average stood at $606.6 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 604166.67% in 2021, then plummeted by 5049.6% in 2022.
  • Quarter analysis of 5 years shows Organon's Cash & Current Investments stood at $737.0 million in 2021, then decreased by 4.21% to $706.0 million in 2022, then decreased by 0.57% to $702.0 million in 2023, then grew by 0.28% to $704.0 million in 2024, then decreased by 4.55% to $672.0 million in 2025.
  • Its Cash & Current Investments was $672.0 million in Q3 2025, compared to $599.0 million in Q2 2025 and $547.0 million in Q1 2025.